Status:

COMPLETED

Compatibility of Participation Levels of Adolescents With Attention Deficit and Hyperactivity Disorder

Lead Sponsor:

Akdeniz University

Conditions:

Attention Deficit Hyperactivity Disorder

Eligibility:

All Genders

12-17 years

Brief Summary

The goal of this study is to assess the agreement between the outcomes of adolescents with attention deficit hyperactivity disorder (ADHD) who participated in Participation and Environment Measurement...

Detailed Description

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in childhood. In addition to fundamental symptoms like inattention and hyperactivity/impulsivity,...

Eligibility Criteria

Inclusion

  • Age between 7 years and 12 years;
  • Diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) by a child and adolescent health psychiatrist, regardless of subtype, according to DSM-V criteria
  • Have cognitive ability to follow instructions for assessment measures

Exclusion

  • Children have any other psychiatric diagnosis like autism spectrum disorder, psychotic symptoms, depression, etc.
  • Children have any neurological or orthopedic disorders like head injury, cerebral palsy, epileptic seizure, visual and speech disorder.

Key Trial Info

Start Date :

September 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 29 2023

Estimated Enrollment :

127 Patients enrolled

Trial Details

Trial ID

NCT05407688

Start Date

September 1 2022

End Date

May 29 2023

Last Update

June 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Akdeniz University

Antalya, Turkey (Türkiye)